8472.TWO GOMAJI Corp. LTD
- Market cap
- TWD 869M
- P/E
- -
- P/B
- 3.71x
- ROE
- -9.0%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 8472.TWO undervalued?
Graham numberThe Graham number of GOMAJI Corp. LTD cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
GOMAJI Corp. LTD fundamental analysis
No fundamental analysis for GOMAJI Corp. LTD yet.
GOMAJI Corp. LTD stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About GOMAJI Corp. LTD
Navicare Biotech Co., Ltd. provides e-commerce and advertising services in Taiwan. It operates an online trading platform that provides online group buying services to consumers, as well as the wholesale and retail of various health foods and beauty products. The company was formerly known as GOMAJI Corp., LTD and changed its name to Navicare Biotech Co., Ltd. in June 2026. The company was founded in 2000 and is based in New Taipei City, Taiwan.
Full company profileGOMAJI Corp. LTD financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
GOMAJI Corp. LTD annual financial statements (TWD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 445M | 414M | 305M | 332M | 389M | 337M | 478M | 497M |
| Gross Profit | 419M | 389M | 284M | 280M | 282M | 212M | 188M | 172M |
| Operating Income | 37.6M | 59.3M | 12.1M | -53.5M | -82.4M | -76.8M | -30.5M | -23.6M |
| EBITDA | 55.9M | 69.7M | 22.5M | -40.5M | -65.7M | -54.1M | 3.54M | 12.6M |
| Net Income | 35.1M | 47.0M | 10.8M | -82.7M | -51.8M | -78.5M | -23.3M | -23.3M |
| EPS | 1.91 | 2.60 | 0.61 | -4.66 | -2.92 | -4.42 | -1.31 | -1.32 |
| Balance Sheet | ||||||||
| Total Assets | 1.17B | 1.16B | 1.05B | 1.21B | 1.18B | 1,000M | 1.05B | 994M |
| Total Liabilities | 612M | 603M | 521M | 796M | 819M | 714M | 779M | 735M |
| Shareholders' Equity | 560M | 558M | 527M | 415M | 364M | 285M | 270M | 259M |
| Cash & Short-term Investments | 114M | 739M | 659M | 243M | 141M | 79.0M | 159M | 67.9M |
| Total Debt | - | 14.4M | 13.3M | 232M | 249M | - | - | - |
| Cash Flow | ||||||||
| Operating Cash Flow | 60.4M | 97.6M | -68.7M | -68.4M | -108M | -63.5M | -3.17M | -103M |
| Capital Expenditure | 324K | 5.42M | 5.77M | 406M | 37.2M | 8.73M | 958K | 0.00 |
| Free Cash Flow | 60.1M | 92.1M | -74.5M | -475M | -145M | -72.2M | -4.12M | -103M |
| Ratios | ||||||||
| ROE | 6.3% | 8.4% | 2.0% | -19.9% | -14.3% | -27.5% | -8.6% | -9.0% |
| ROA | 3.0% | 4.0% | 1.0% | -6.8% | -4.4% | -7.8% | -2.2% | -2.3% |
| Net Profit Margin | 7.9% | 11.3% | 3.5% | -24.9% | -13.3% | -23.3% | -4.9% | -4.7% |
| Debt to Equity | - | 0.03x | 0.03x | 0.56x | 0.68x | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
GOMAJI Corp. LTD dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- Jul 19, 2022
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | TWD 9.76M | 0.55 | - |
| 2021 | TWD 44.3M | 2.50 | 411.6% |
| 2020 | TWD 31.7M | 1.76 | 67.6% |
| 2019 | TWD 10.2M | 0.55 | 28.9% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns GOMAJI Corp. LTD
- Insiders 73.26%
- Institutions 0.00%
- Public & others 26.74%
- Shares outstanding 17.7M
- Free float 5.90M
GOMAJI Corp. LTD company profile
- Company name
- GOMAJI Corp. LTD
- Ticker
- 8472.TWO
- Exchange
- Taiwan OTC Exchange
- Sector
- Consumer Cyclical
- Industry
- Internet & Direct Marketing Retail
- Fiscal year end
- December
- Address
- No. 262, Section 2, New Taipei City, Taiwan
- Phone
- 886 2 2711 8177
- Website
- gomaji.com
About GOMAJI Corp. LTD
Navicare Biotech Co., Ltd. provides e-commerce and advertising services in Taiwan. It operates an online trading platform that provides online group buying services to consumers, as well as the wholesale and retail of various health foods and beauty products. The company was formerly known as GOMAJI Corp., LTD and changed its name to Navicare Biotech Co., Ltd. in June 2026. The company was founded in 2000 and is based in New Taipei City, Taiwan.
GOMAJI Corp. LTD management
10- Ms. Suzhen ChenCEO & Director
- Mr. Kai-Zhen WuChief Strategy Officer & Director
- Mr. Jinchang WuPresident & Chairman
- Yi-Ting LiaoFinancial Officer & Accounting Officer
- Hsia IvyCOO & Chief Information Security Officer
- Vanessa ChangLegal Manager & Chief Information Security Officer
- Ms. Ju Chou LingManager of Human Resources
- Chih Lee YiChief Internal Audit Officer
- Kai Wen ShiGeneral Manager
- Qian Hui XiaDeputy General Manager